ESC 365 - Non-vitamin K oral anticoagulants for cardioversion: recent trials.

ESC Premium Access

Non-vitamin K oral anticoagulants for cardioversion: recent trials.

Session: Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty

Topic: Atrial fibrillation (AF)

Speaker: Professor M. Ezekowitz (Philadelphia, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Michael Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)

4 presentations

0 follower

3 more presentations in this session

Early cardioversion: is there strong evidence to support the concept?

Speaker: Professor P. Kirchhof (Hamburg, DE)

Practical considerations for cardioversion of atrial fibrillation.

Speaker: Doctor R. Cappato (Milan, IT)

Dealing with left atrial appendage clot

Speaker: Associate Professor F. Marin (Murcia, ES)

Access the full session

Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty

Speakers: Professor M. Ezekowitz, Professor P. Kirchhof, Doctor R. Cappato, Associate Professor F. Marin

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources